ADC Therapeutics AG
Biotechnology · Epalinges, Vaud
ADC Therapeutics AG is a Swiss biotechnology company based in Epalinges, Canton of Vaud (UID CHE-461.408.645).
Board members & signatories
- Mallik Ameet — Mitglied des Verwaltungsrates
- Bizzari Jean Pierre — Mitglied des Verwaltungsrates
- Squarer Ron — Mitglied des Verwaltungsrates
Registered purpose
La Société a pour but la recherche, le développement, la production et la vente de produits dans les domaines de la biotechnologie, de la pharmaceutique, de la technologie médicale, du diagnostic et de la thérapie ainsi que l'acquisition, la vente et l'utilisation de brevets et de licences dans ces domaines (pour but complet cf. statuts).…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What ADC Therapeutics does
OFFERING
ADC Therapeutics develops targeted antibody drug conjugate treatments for cancer therapy. Their primary product, ZYNLONTA® (loncastuximab tesirine-lpyl), is FDA-approved for treating adults with certain types of large B-cell lymphoma that have relapsed or are refractory after two or more treatments.
Unlock the full analysis →Similar companies
- CORETAG Therapeutics AG — Pharmaceuticals · Basel
- Elthera AG — Biotechnology · Zug
- Therakles Pharmaceuticals AG — Pharmaceuticals · Baar
- Athebio AG — Biotechnology · Schlieren
- Alphathera AG — Pharmaceuticals · Basel
- Numab Therapeutics AG — Biotechnology · Horgen
Find every biotechnology company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned biotechnology companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime